Treating patients with early axial spondyloarthritis to target – a 1 year randomized controlled study taking an intense treatment approach versus routine treatment (STRIKE)

Registry ID

EUCTR2015-005398-18

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE4

Sponsor

AbbVie Deutschland GmbH & Co. KG

Start date

2016-05-12

Completion date

2018-01-31

Last update

2026-08-16

Conditions

• Axial spondyloarthritis

Summary

To compare a treat-to-target (T2T) intense treatment approach with a routine treatment approach (Standard of Care [SOC]) in reducing disease activity at week 32 in patients with axial spondyloarthritis (axSpA).

Locations

• , , Germany

Related clinical trials

• EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)

View on source registry